Guy Chamberland

Victhom Laboratory, Inc. is a company which owns patents in the field of orthotics and prosthetics including intellectual property used in the Power Knee. Victhom Laboratory was founded on January 11, 2002 and is headquartered in Montreal, Canada.

Excel-Tech Ltd. engages in the manufacture of musculoskeletal therapy equipment. It designs and produces neuromuscular and neurophysiological instruments. Its IP-enabled medical solutions address the complete spectrum of monitoring and diagnosis of conditions affecting the central and peripheral nervous systems. The company was founded by John Mumford in 1985 and is headquartered in Oakville, Canada.

Smith & Nephew, Inc. develops and markets medical devices. Its products include television cameras and monitors, endoscopes, arthroscopes, orthopedic hand owered instruments, fiber optic illumination systems, laparoscopes, and surgical instruments. The company was founded on November 27, 1975 and is headquartered in Memphis, TN.

Amadeus International, Inc. operates as a development stage company. It focuses on the marketing of software solutions, such as enterprise quality resource planning, and enterprise quality & compliance management. The company was founded on December 22, 2004 and is headquartered in Quebec, Canada.

PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada.

Resonant Medical Inc. develops, manufactures and distributes 3D ultrasound image-guided adaptive radiotherapy products. The company was founded by Fred Francis, Tony Falco and Luc Sirois and is headquartered in Montréal, CA.

Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada.

CardioInsight Technologies, Inc. manufactures and develops electrocardiographic mapping technology. It has developed a novel three dimensional (3D) non-invasive Electrocardiographic Mapping technology platform combining body surface electrical data with heart-torso anatomy to provide single beat epicardial 3D electroanatomic maps of the whole heart. Its ECVUE™ system non-invasively generates real-time, whole heart images of the electrical activity on the surface of the heart by combining body surface electrical data with 3D anatomical data. It then reconstructs and displays 3D maps and other useful measures of cardiac electrical activity as if the measurements were taken directly from the surface of the heart. The company was founded by Charu Ramanathan in 2006 and is headquartered in Cleveland, OH.

The Canadian Cancer Society operates as a non-profit organization that provides cancer charity services. It offers support and services and programs for the prevention and screening of cancer. The company was founded in 1938 and is headquartered in Toronto, Canada.

DeCell Technologies, Inc. develops advanced tissue products for use in wound healing and surgical reconstructions. It operates as a biomedical device manufacturer. The company was founded by Sean Margueratt and Paul Gratzer in 2012 and is headquartered in Halifax, Canada.

SoundBite Medical Solutions Inc. offers medical devices. It develops and commercializes proprietary shockwave device and generator technology. The company was founded by Steve Arless, Martin Brouillette, Louis-Philippe Riel and Steven Dion and is headquartered in Montreal, Canada.

Proteocyte Diagnostics, Inc. develops prognostic oral precancer laboratory, which objectively and accurately detects oral lesions. The company was founded in 2011 and is headquartered in Toronto, Canada.